Chairman and CEO:		James M. Cornelius
Headquarters:		345 Park Avenue New York, New York, USA 10154-0037 212-546-4000
Website Address:		www.bms.com
Stock Exchange Listing:		BMY (NYSE)
Number of Employees:		42,000
Global Sales:		$19.3 billion
Patient Assistance:		During 2007, the Bristol-Myers Squibb Patient Assistance Foundation and company-sponsored programs under the LifeLines of Care initiative assisted more than 290,000 indigent patients in the U.S. in filling prescriptions with pharmaceuticals valued at more than $236 million at wholesale prices.
Businesses:		Pharmaceuticals Mead Johnson Nutritionals ConvaTec (Ostomy Care and Wound Therapeutics)
Selected Key Products:		Abilify® (aripiprazole) Atripla™ (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tablets Avapro® (irbesartan) Tablets / Avalide® (irbesartan-hydrochlorothiazide) Tablets Baraclude® (entecavir) ConvaTec Ostomy Care ConvaTec Wound Therapeutics Coumadin® (Warfarin Sodium Tablets, USP) Crystalline EMSAM® (selegiline transdermal system) Enfamil® (infant formula) Erbitux® (Cetuximab) IXEMPRA™ (ixabepilone) for injection Orencia® (abatacept) Plavix® (clopidogrel bisulfate) Pravachol® (pravastatin sodium) Tablets Reyataz® (atazanavir sulfate) Sprycel® (dasatinib) Tablets Sustiva® (efavirenz)

Please click on the product name to see Full Prescribing Information including boxed WARNINGS for Abilify®, Atripla™, Baraclude®, Coumadin®, EMSAM®, Erbitux® and IXEMPRA™, including boxed WARNING for Avapro® / Avalide® regarding use in pregnancy. As soon as pregnancy is detected, discontinue use of Avapro® / Avalide®.

Data above as reported in the Bristol-Myers Squibb 2007 Annual Report

Bristol-Myers Squibb's European and French headquarters in Rueil-Malmaison, France

Our employees work in offices, research and development labs, manufacturing plants and distribution facilities located in almost every country around the world.